T2 Biosystems, Inc. guidance for the full year 2022 remains unchanged. The company expected total revenue of $28 million to $31 million, including product revenue of $16 million to $17 million and research contribution revenues of $12 million to $14 million. The company continue to expect to close 60 to 70 T2Dx Instrument contracts in 2022 and COVID-19 revenue to decrease from $9.5 million to $3.5 million.